Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Satellos Bioscience Inc market cap is $180.1M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Satellos Bioscience Inc 52 week high is $13.39 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Satellos Bioscience Inc 52 week low is $4.53 as of November 15, 2026.
Satellos Bioscience Inc stock price today is $9.61.
Satellos Bioscience Inc stock price yesterday was $11.65.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Satellos Bioscience Inc's P/E ratio is -7.42.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Satellos Bioscience Inc P/B ratio is 5.2851.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Satellos Bioscience Inc 50-day moving average is $9.83.
